SANION.ST Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 11:22):

Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark...

Stats
Today's Volume	1.07M
Average Volume	310 584
Market Cap	267.53M
EPS	SEK0 ( 2024-05-29 )
Next earnings date	( SEK0 ) 2024-08-28
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	-2.43
ATR14	SEK0.0190 (0.79%)

Volume Correlation

Long: 0.01 (neutral)

Short: 0.49 (neutral)

Signal:(49.6) Neutral

Saniona AB (publ) Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Saniona AB (publ) Correlation - Currency/Commodity

0.53
( weak )

0.00
( neutral )

0.36
( neutral )

-0.59
( weak negative )

Saniona AB (publ) Financials

Annual	2023
Revenue:	SEK16.84M
Gross Profit:	SEK-78.27M (-464.78 %)
EPS:	SEK-1.290

FY	2023
Revenue:	SEK16.84M
Gross Profit:	SEK-78.27M (-464.78 %)
EPS:	SEK-1.290

FY	2022
Revenue:	SEK15.28M
Gross Profit:	SEK10.81M (70.72 %)
EPS:	SEK-3.33

FY	2021
Revenue:	SEK10.48M
Gross Profit:	SEK5.85M (55.81 %)
EPS:	SEK-6.59

Financial Reports:

No articles found.

Saniona AB (publ) Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Saniona AB (publ)

Saniona AB (publ), a rare disease biopharmaceutical company, engages in the research, development, and commercialization of treatments for the central nervous system in Denmark. The company's products include Tesofensine, a monoamine reuptake inhibitor; and Tesomet, a fixed dose combination of tesofensine and metoprolol that has completed the Phase 2 clinical trials for the treatment of prader-willi syndrome and hypothalamic obesity. It also develops SAN711, which is in Phase 1 clinical stage for rare neuropathic disorders; SAN903 that is in preclinical stage for rare inflammatory, fibrotic, and hematological disorders. The company has research and collaboration agreements with Boehringer Ingelheim International GmbH; license agreement with Productos Medix, S.A. de C.V.; research services agreement and a collaboration agreement with Cephagenix ApS. Saniona AB (publ) was founded in 2011 and is headquartered in Glostrup, Denmark.